Navigation Links
Global Javlor (Bladder Cancer) Market - Worldwide Industry Share, Size, Players, Opportunity, Analysis and Forecasts to 2020

Albany, New York (PRWEB) August 14, 2013

GlobalDatas pharmaceuticals report, Javlor (Bladder Cancer) Analysis and Forecasts to 2020, provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Bladder Cancer market.

To check out the Complete table of contents, visit:

This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.


Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Javlor including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Javlor including efficacy, safety, pricing, competition and other details which influence its sales potential
Global sales forecast for 2010-2020 for Javlor

Browse All the Report of This Publisher, Visit:

Reasons to Buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

Browse All Reports of This Category, Visit:

Table of Contents

1 Table of contents 2
1.1 List of Tables 2
1.2 List of Figures 2

2 Introduction 4
2.1 Bladder Cancer Market 4
2.2 Bladder Cancer Disease 4
2.3 GlobalData Pipeline Report Guidance 7

3 Baldder Cancer Disease: Market Characterization 8
3.1 Bladder Cancer Disease Market 8
3.2 Bladder Cancer Disease Market Forecasts and CAGR 8
3.3 Drivers for the Bladder Cancer Disease Market 8
3.3.1 High Prevalence 9
3.3.2 High Incidence 9
3.3.3 High Survival Rate 10
3.3.4 High lifetime costs 10

4 TNM Classification of bladder cancer 11
4.1 American Urological Association 11

To Buy the Copy of This Report, Visit:

5 Javlor 14
5.1 Introduction 14
5.2 Mechanism of Action 14
5.3 Clinical Studies 14
5.4 Approval History of Javlor 15
5.5 Sales drivers 15
5.5.1 Bladder Cancer Market 15
5.5.2 Targeting the Niche Market 15
5.5.3 Improved Survival 15
5.5.4 Mechanism of Action 15
5.5.5 No Competition 16
5.6 Drug Evaluation 16
5.6.1 Efficacy 16
5.6.2 Safety 16
5.6.3 Compliance 17
5.6.4 Dosing Convenience 17
5.6.5 Competition 17
5.7 Sales forecast 17
5.7.1 Target patient Pool of Javlor 17
5.7.2 Market Penetration 18
5.7.3 Annual Cost of Therapy 19
5.7.4 Sales Projections of Javlor 19

6 Bladder Cancer Market: Appendix 19
6.1 Market Definitions 19
6.2 List of Abberiviations 19
6.3 Research Methodology 19
6.3.1 Coverage 19
6.3.2 Secondary Research 19
6.3.3 Forecasting 20
6.3.4 Number of Patients Approved to take the Drug 20
6.3.5 Net Penetration of Drug 20
6.3.6 Net Annual Dosing 20
6.3.7 Annual Cost of Therapy 21
6.3.8 Primary Research 21
6.3.9 Expert Panels 21
6.4 Contact Us 21
6.5 Disclaimer 21
6.6 Sources 21
Table 1: Bladder Cancer Incidences & Mortality 5
Table 2: Bladder Cancer, Global, Market Forecast ($bn), 20092020 8
Table 3: Approval History of Javlor 15
Figure 1: Percentage Distribution of Top 20 Diagnosed Cancers 4
Figure 2: Fatality = [(%Distribution of Incidence) (% Distribution Mortality )] of Top 20 Cancers 5
Figure 3: Percentage share of risk factors in Developed Countries 6
Figure 4: Percentage share of risk factors in Developing Countries 6
Figure 5: Smoking Consumption Curve, US (1960-2006) 6
Figure 6: Bladder Cancer, Global, Market Forecasts ($bn), 2009-2020 8
Figure 7: All Cancer Incidence Worldwide 9
Figure 8: Bladder Cancer Incidence Worldwide 9
Figure 9: Broad Classification of Bladder Cancer 11
Figure 10: Classification of NMI Bladder Cancer 11
Figure 11: Detailed TNM Classifications 12
Figure 12: Classification of NMI Bladder Cancer 13
Figure 13: Drug Model Diagram of Javlor 18
Figure 14: Global Forecasted Sales of Javlor ($m) 2010-2020 19
Figure 15: Distribution of Javlor Sales in Major Countries, 2010 20

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... District , the only authorized OSHA Training Institute Education Center headquartered in Northern ... protecting their workers from extreme heat at their worksites. Employers with workers ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology: